A plastic EMP1⁺ to LGR5⁺ cell state conversion as a therapeutic bypass to KRAS-G12D inhibition in metastatic colorectal cancer [SLAM-Seq]
RNA-seq (gene expression) · mouse · 15 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 15 samples: 5 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal CancerCancer discovery · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE294822_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1251649 and SRA study SRP579104. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 15 samples.
How we read this: 5 replicated groups read from 15 sample titles; they account for 15 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8921823 AKTP MTO mouse tumor organoids, RM-044 2.5h, replicate 1 AKTP MTO mouse tumor or…
- GSM8921824 AKTP MTO mouse tumor organoids, RM-044 2.5h, replicate 2 AKTP MTO mouse tumor or…
- GSM8921825 AKTP MTO mouse tumor organoids, RM-044 2.5h, replicate 3 AKTP MTO mouse tumor or…
- GSM8921827 AKTP MTO mouse tumor organoids, RM-044 6h, replicate 1 AKTP MTO mouse tumor or…
- GSM8921828 AKTP MTO mouse tumor organoids, RM-044 6h, replicate 2 AKTP MTO mouse tumor or…
- GSM8921829 AKTP MTO mouse tumor organoids, RM-044 6h, replicate 3 AKTP MTO mouse tumor or…
- GSM8921830 AKTP MTO mouse tumor organoids, RM-044 10h, replicate 1 AKTP MTO mouse tumor or…
- GSM8921831 AKTP MTO mouse tumor organoids, RM-044 10h, replicate 2 AKTP MTO mouse tumor or…
- GSM8921832 AKTP MTO mouse tumor organoids, RM-044 10h, replicate 3 AKTP MTO mouse tumor or…
- GSM8921833 AKTP MTO mouse tumor organoids, RM-044 14h, replicate 1 AKTP MTO mouse tumor or…
- GSM8921834 AKTP MTO mouse tumor organoids, RM-044 14h, replicate 2 AKTP MTO mouse tumor or…
- GSM8921836 AKTP MTO mouse tumor organoids, RM-044 14h, replicate 3 AKTP MTO mouse tumor or…
- GSM8921837 AKTP MTO mouse tumor organoids, vehicle control, replicate 1 AKTP MTO mouse tumor or…
- GSM8921838 AKTP MTO mouse tumor organoids, vehicle control, replicate 2 AKTP MTO mouse tumor or…
- GSM8921839 AKTP MTO mouse tumor organoids, vehicle control, replicate 3 AKTP MTO mouse tumor or…
- GSE303692 A plastic EMP1⁺ to LGR5⁺ cell state conversion as a therapeutic bypass to KRAS-G12D inhibition in metastatic colorectal cancer [RNA-Seq] 24 samples shares kras-g12d, emp1, lgr5, therapeutic, conversion, inhibition, metastatic, colorectal
- GSE304518 A plastic EMP1⁺ to LGR5⁺ cell state conversion as a therapeutic bypass to KRAS-G12D inhibition in metastatic colorectal cancer 12 samples shares kras-g12d, emp1, lgr5, therapeutic, conversion, inhibition, metastatic, colorectal
- GSE223323 Enterocyte like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability 148 samples shares therapeutic, colorectal
- GSE293450 Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma 38 samples shares therapeutic, metastatic
- GSE326721 Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy [RNASeq_LSM] 16 samples shares therapeutic, inhibition
- GSE269680 CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRASG12D inhibition in pancreatic ductal adenocarcinoma (spatial) 15 samples shares therapeutic, inhibition
- GSE326720 Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy [RNASeq_MAVA] 13 samples shares therapeutic, inhibition
- GSE301496 Transient YAP/TAZ inhibition exposes therapeutic vulnerabilities in advanced cancers [CUT&Run] 20 samples shares therapeutic, inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.